Oregon Clinical & Translational Research Institute, Oregon Health & Science University, Portland, OR 97239, USA.
OHSU Library, Oregon Health & Science University Library, Portland, OR 97239, USA.
Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz114.
While abnormalities related to carbohydrates (glycans) are frequent for patients with rare and undiagnosed diseases as well as in many common diseases, these glycan-related phenotypes (glycophenotypes) are not well represented in knowledge bases (KBs). If glycan-related diseases were more robustly represented and curated with glycophenotypes, these could be used for molecular phenotyping to help to realize the goals of precision medicine. Diagnosis of rare diseases by computational cross-species comparison of genotype-phenotype data has been facilitated by leveraging ontological representations of clinical phenotypes, using Human Phenotype Ontology (HPO), and model organism ontologies such as Mammalian Phenotype Ontology (MP) in the context of the Monarch Initiative. In this article, we discuss the importance and complexity of glycobiology and review the structure of glycan-related content from existing KBs and biological ontologies. We show how semantically structuring knowledge about the annotation of glycophenotypes could enhance disease diagnosis, and propose a solution to integrate glycophenotypes and related diseases into the Unified Phenotype Ontology (uPheno), HPO, Monarch and other KBs. We encourage the community to practice good identifier hygiene for glycans in support of semantic analysis, and clinicians to add glycomics to their diagnostic analyses of rare diseases.
虽然与碳水化合物(聚糖)相关的异常在罕见和未确诊疾病以及许多常见疾病的患者中很常见,但这些与聚糖相关的表型(糖表型)在知识库 (KB) 中并没有很好地体现。如果与聚糖相关的疾病得到更有力的代表和糖表型的编辑,它们可以用于分子表型分析,以帮助实现精准医学的目标。通过利用临床表型的本体论表示,使用人类表型本体 (HPO) 和模型生物本体(如哺乳动物表型本体 (MP)),在 Monarch 计划的背景下,对基因型-表型数据进行跨物种的计算比较,促进了罕见疾病的诊断。在本文中,我们讨论了糖生物学的重要性和复杂性,并回顾了现有 KB 和生物本体中与聚糖相关内容的结构。我们展示了如何通过语义结构糖表型的注释知识来增强疾病诊断,并提出了一种将糖表型和相关疾病整合到统一表型本体 (uPheno)、HPO、Monarch 和其他 KB 中的解决方案。我们鼓励社区支持语义分析,为聚糖制定良好的标识符卫生规范,并鼓励临床医生在对罕见疾病进行诊断分析时加入糖组学。